Content 10/12/2019 Ensuring consistent access to donor starting material throughout... An interview with Dominic Clarke, Global Head of Cell Therapy at HemaCare
Content 06/12/2019 CASE STUDY: Customised Bioreactor Design Charter Medical take a collaborative, engineer-led approach to custom bioreactor design
Content 19/11/2019 Reducing complexity in clinical translation and scale-up of... An interview with Dr Jon Rowley, Founder and Chief Product Officer, RoosterBio, Inc
Content 08/11/2019 The A-Z of Advanced Therapies Phacilitate's picks of the A to Z of advanced therapies
Content 07/11/2019 Phacilitate Working Group Report: Standardising Tubing Connectivity A summary report of the working group for sterile tubing connectivity meeting to discuss guidance documentation
Content 07/11/2019 Accelerating Advanced Therapy Treatments with the FDA’s RMAT... An introduction to the FDA’s RMAT designation with Dr Julie Allickson, Director, Regenerative Medicine Clinical Center at Wake Forest Institute for...
Content 29/10/2019 Innovations for Scalable Manufacturing of Allogeneic Cell Therapy... Allogeneic cell therapies are poised to become a new frontier for therapeutic medicines. However, reliable and scalable manufacturing technology is...
Content 21/10/2019 [WEBINAR] Is a non-viral gene editing approach the answer to... Exploring the next generation of non-viral gene-editing technologies, in partnership with Avectas
Content 09/10/2019 Automation Special Interest Group: Report 2019 The 2019 Automation SIG identified some of the biggest opportunities to improve manufacturing efficiency and accuracy. This report comprises 14...
Content 08/10/2019 [WEBINAR] Overcoming the shortages in cell and gene therapy... A panel of advanced therapy manufacturing experts explore strategies to overcome the global manufacturing shortage
Content 07/10/2019 [Blog] Measuring success from conferences is getting harder, here&... A case study from the Business of Regenerative Medicine 2019
Content 07/10/2019 60 seconds with... Dr Angela Colbert, Knight Vice President Education at the Frost Science Museum, Miami
Content 25/09/2019 Functionality of non-virally transfected T cells A summary of Dr Shirley O'Dea's presentation and data from Phacilitate Leaders Europe
Content 12/09/2019 60 Seconds with...Frances Pang, Orchard Therapeutics Frances Pang, VP Global Market Access at Orchard Therapeutics on evolving access and reimbursement structures, HTA engagement and commercial success
Content 03/09/2019 60 Seconds with...Pilar Pinilla-Dominguez, NICE Pilar Pinilla-Dominguez, Senior Scientific Adviser at NICE on reimbursement models for advanced therapies
